Index S&P 500
P/E 34.72
EPS (ttm) 1.73
Insider Own 0.47%
Shs Outstand 317.61M
Perf Week 13.84%
Market Cap 19.09B
Forward P/E 19.01
EPS next Y 3.16
Insider Trans -3.88%
Shs Float 316.12M
Perf Month 11.05%
Enterprise Value 21.93B
PEG 2.11
EPS next Q 0.64
Inst Own 101.90%
Short Float 3.60%
Perf Quarter 19.69%
Income 579.20M
P/S 3.71
EPS this Y 8.17%
Inst Trans -1.24%
Short Ratio 3.34
Perf Half Y 26.70%
Sales 5.14B
P/B 2.92
EPS next Y 7.86%
ROA 4.50%
Short Interest 11.38M
Perf YTD 8.89%
Book/sh 20.59
P/C 50.85
EPS next 5Y 9.00%
ROE 7.78%
52W High 62.77 -4.22%
Perf Year 0.39%
Cash/sh 1.18
P/FCF 19.52
EPS past 3/5Y -6.15% -16.65%
ROIC 6.61%
52W Low 45.49 32.16%
Perf 3Y 21.15%
Dividend Est. 0.31 (0.52%)
EV/EBITDA 16.29
Sales past 3/5Y -10.62% -2.14%
Gross Margin 67.38%
Volatility 5.24% 2.98%
Perf 5Y 19.77%
Dividend TTM 0.24 (0.40%)
EV/Sales 4.26
EPS Y/Y TTM -26.75%
Oper. Margin 17.67%
ATR (14) 1.73
Perf 10Y -
Dividend Ex-Date Nov 28, 2025
Quick Ratio 0.58
Sales Y/Y TTM -17.48%
Profit Margin 11.26%
RSI (14) 70.04
Recom 3.00
Dividend Gr. 3/5Y 0.00% 0.00%
Current Ratio 0.71
EPS Q/Q -3.33%
SMA20 9.02%
Beta 1.07
Target Price 61.38
Payout 16.18%
Debt/Eq 0.50
Sales Q/Q -30.72%
SMA50 9.67%
Rel Volume 1.98
Prev Close 60.20
Employees 18000
LT Debt/Eq 0.36
Earnings Feb 04 BMO
SMA200 16.20%
Avg Volume 3.40M
Price 60.12
IPO Jun 13, 2016
Option/Short Yes / Yes
EPS/Sales Surpr. 7.41% 2.63%
Trades
Volume 6,733,381
Change -0.13%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-16-26 Downgrade
JP Morgan
Neutral → Underweight
$57
Jan-05-26 Downgrade
Mizuho
Outperform → Underperform
$51
Oct-15-25 Downgrade
JP Morgan
Overweight → Neutral
$53
Sep-02-25 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$50
Aug-14-25 Downgrade
Barclays
Overweight → Equal Weight
$54
Jul-31-25 Downgrade
Truist
Buy → Hold
$55
Jul-22-25 Downgrade
Melius
Buy → Hold
$62
Jul-15-25 Downgrade
TD Cowen
Buy → Hold
$50
Apr-09-25 Downgrade
Exane BNP Paribas
Outperform → Neutral
$67
Dec-09-24 Downgrade
Citigroup
Buy → Neutral
$92 → $86
Nov-18-24 Downgrade
Argus
Buy → Hold
Nov-13-24 Initiated
UBS
Neutral
$84
Oct-10-24 Upgrade
JP Morgan
Neutral → Overweight
$90 → $92
Sep-06-24 Upgrade
Mizuho
Neutral → Outperform
$80 → $90
Sep-06-24 Initiated
Morgan Stanley
Overweight
$89
Sep-06-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Sep-05-24 Upgrade
Raymond James
Mkt Perform → Outperform
Jul-08-24 Upgrade
TD Cowen
Hold → Buy
$75 → $90
Apr-17-24 Downgrade
JP Morgan
Overweight → Neutral
$95 → $90
Mar-14-24 Initiated
Truist
Buy
$99
Show Previous Ratings
Feb-06-26 09:13AM
Feb-05-26 12:08PM
09:00AM
02:28AM
01:13AM
12:37AM
Loading…
12:37AM
Feb-04-26 06:01PM
01:26PM
12:26PM
11:29AM
11:12AM
10:03AM
09:30AM
07:59AM
07:30AM
10:09PM
Loading…
Feb-02-26 10:09PM
04:30PM
Jan-28-26 08:29AM
Jan-21-26 07:18AM
Jan-20-26 08:00AM
03:00AM
Jan-16-26 09:32AM
Jan-15-26 09:00AM
Jan-13-26 07:29AM
Jan-11-26 11:05PM
Jan-07-26 04:30PM
Jan-05-26 10:00AM
Dec-26-25 09:08AM
Dec-24-25 08:52AM
Dec-12-25 03:46PM
03:15AM
Loading…
Dec-09-25 03:15AM
Dec-02-25 04:34PM
Nov-27-25 10:38PM
Nov-25-25 08:53AM
Nov-24-25 07:08AM
Nov-13-25 09:11AM
Nov-12-25 07:54AM
Nov-11-25 05:48AM
Nov-07-25 08:34AM
Nov-06-25 09:30AM
Nov-05-25 04:30PM
09:32AM
12:39AM
Nov-04-25 10:09AM
Nov-03-25 11:00AM
Oct-31-25 08:46AM
07:30AM
Oct-30-25 11:13AM
08:04AM
08:00AM
01:38AM
Oct-29-25 03:04PM
01:11PM
09:30AM
08:17AM
07:30AM
Oct-27-25 11:09PM
Oct-20-25 11:32PM
Oct-15-25 09:36AM
Oct-11-25 01:36PM
Oct-09-25 08:56AM
Oct-01-25 07:30AM
03:00AM
Sep-16-25 06:18AM
Sep-11-25 02:16PM
Sep-08-25 10:10AM
Sep-02-25 09:45AM
07:00AM
Aug-27-25 04:30PM
04:15PM
Aug-21-25 09:39AM
Aug-19-25 09:56AM
12:40AM
Aug-13-25 02:31AM
12:31AM
Aug-12-25 11:46PM
11:39PM
12:30PM
Aug-11-25 05:00PM
Aug-07-25 10:38AM
Aug-01-25 10:39AM
10:34AM
Jul-31-25 10:30AM
09:46AM
Jul-30-25 03:41PM
10:00AM
08:54AM
08:21AM
(Associated Press Finance)
07:30AM
Jul-28-25 11:17PM
Jul-23-25 10:00AM
Jul-22-25 12:07AM
Jul-21-25 08:30AM
Jul-19-25 02:37AM
Jul-07-25 10:01AM
Jul-02-25 04:15PM
10:29AM
Jul-01-25 08:00AM
Jun-30-25 04:07PM
06:01AM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Underwood Peter C SVP - Chief Legal Officer Nov 10 '25 Option Exercise 28.92 58,133 1,681,206 138,208 Nov 12 04:46 PM Underwood Peter C SVP - Chief Legal Officer Nov 10 '25 Sale 51.28 58,133 2,981,060 80,075 Nov 12 04:46 PM Underwood Peter C Officer Nov 10 '25 Proposed Sale 51.28 58,133 2,980,795 Nov 10 03:19 PM Walker Stacey A. SVP - Chief People Officer Oct 31 '25 Sale 50.35 2,192 110,367 59,488 Nov 03 08:23 PM Walker Stacey A. Officer Oct 31 '25 Proposed Sale 50.35 2,192 110,360 Oct 31 01:12 PM Okerstrom Mark D Chief Financial Officer Aug 01 '25 Buy 47.03 21,300 1,001,739 94,622 Aug 04 07:46 PM LICO JAMES A President and CEO May 15 '25 Sale 72.40 175,000 12,670,000 428,585 May 16 05:04 PM LICO JAMES A Officer May 15 '25 Proposed Sale 72.39 175,000 12,669,125 May 15 04:43 PM Underwood Peter C SVP - Chief Legal Officer May 12 '25 Sale 73.88 14,327 1,058,479 51,750 May 13 07:41 PM Underwood Peter C Officer May 12 '25 Proposed Sale 73.88 14,327 1,058,417 May 12 04:06 PM Walker Stacey A. SVP - Human Resources Feb 28 '25 Sale 79.05 3,002 237,308 42,373 Mar 04 05:21 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '25 Option Exercise 35.84 16,467 590,177 108,211 Mar 04 05:19 PM McLaughlin Charles E SVP - Chief Financial Officer Feb 28 '25 Sale 78.86 32,085 2,530,223 76,126 Mar 04 05:19 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 26 '25 Sale 79.95 6,493 519,115 24,283 Feb 28 06:02 PM Mulhall Christopher M. VP - Chief Accounting Officer Feb 26 '25 Sale 80.12 1,395 111,767 5,815 Feb 28 06:02 PM Walker Stacey A. SVP - Human Resources Feb 26 '25 Sale 80.52 5,688 457,998 47,141 Feb 28 06:02 PM Walker Stacey A. Officer Feb 28 '25 Proposed Sale 79.05 3,002 237,302 Feb 28 02:13 PM McLaughlin Charles E Officer Feb 28 '25 Proposed Sale 78.86 32,085 2,530,259 Feb 28 01:24 PM LICO JAMES A President and CEO Feb 24 '25 Option Exercise 35.35 335,999 11,877,853 724,968 Feb 26 07:10 PM LICO JAMES A President and CEO Feb 24 '25 Sale 80.38 196,117 15,763,884 528,851 Feb 26 07:10 PM Walker Stacey A. Officer Feb 26 '25 Proposed Sale 80.52 5,688 457,978 Feb 26 12:01 PM LICO JAMES A Officer Feb 24 '25 Proposed Sale 80.38 196,117 15,763,195 Feb 24 04:19 PM